nach oben

Rheumatology International

Erschienen in:

01.10.2011 | Original Article

The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients

verfasst von: Ebru Onalan Etem, Halit Elyas, Salih Ozgocmen, Arefe Yıldırım, Ahmet Godekmerdan

Erschienen in: Rheumatology International | Ausgabe 10/2011

Einloggen, um Zugang zu erhalten

Abstract

Toll-like receptors (TLRs) play an important role in the induction and regulation of the innate immune system or adaptive immune responses. Genetic variations within human TLRs have been reported to be associated with a range of immune-related diseases. This study was conducted to investigate the frequencies of TLR3 rs3775290, TLR9 rs187084, and TLR10 rs4129009 polymorphisms and to detect between polymorphisms and autoantibody positive as RF, collagen type II, anti-RNP, and anti-CCP in patient group. We performed a case–control study of 100 rheumatoid arthritis (RA) cases and 100 healthy controls matched on age, sex, and residence. All polymorphisms in TLRs were determined by polymerase chain reaction-based restriction fragment length polymorphism. Serum autoantibody level was measured using quantitative ELISA. SNPs were genotyped in all samples. Our results showed that TT genotype for SNP 1237 T/C increased the RA risk significantly (p < 0.05). No statistically significant differences were found in the TLR3 and TLR10 genotypes or allele distribution between RA patients and control individuals. No associations were noted with autoantibody production and TLR3, TLR9, and TLR10 polymorphisms genotypes (p > 0.05). Our study suggests that a single nucleotide polymorphism (rs187084) in TLR9 gene may be a susceptibility factor for RA in Turkish population. Further studies are required to explore the role of TLRs gene polymorphisms in the risk of RA, especially in ethnically different populations to confirm our results.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N et al (2004) Expression of Toll-like receptor 2 on CD16 + blood monocytes and synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum 50:1457–1467PubMedCrossRef

Sobek V, Birkner N, Falk I, Wurch A, Kirschning CJ, Wagner H et al (2004) Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res Ther 6:433–446CrossRef

Pierer M, Rethage J, Seibl R, Lauener R, Brentano F, Wagner U et al (2004) Chemokine secretion of rheumatoid arthritis synovial fibroblasts stimulated by Toll-like receptor 2 ligands. J Immunol 172:1256–1265PubMed

Seibl R, Birchler T, Loeliger S, Hossle JP, Gay RE, Saurenmann T et al (2003) Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium. Am J Pathol 162:1221–1227PubMedCrossRef

Kyburz D, Rethage J, Seibl R, Lauener R, Gay RE, Carson DA et al (2003) Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll-like receptor signaling. Arthritis Rheum 48:642–650PubMedCrossRef

Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376PubMedCrossRef

Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5:987–995PubMedCrossRef

Aderem A, Ulevitch RJ (2000) Toll-like receptors in the induction of the innate immune response. Nature 406:782–787PubMedCrossRef

Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145PubMedCrossRef

10.

Le Bon A, Tough DF (2002) Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14:432–436PubMedCrossRef

11.

Lawton JA, Ghosh P (2003) Novel therapeutic strategies based on toll-like receptor signaling. Curr Opin Chem Biol 7:446–451PubMedCrossRef

12.

Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M et al (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745PubMedCrossRef

13.

Fuxman Bass JI, Gabelloni ML, Alvarez ME, Vermeulen ME, Russo DM, Zorreguieta A et al (2008) Characterization of bacterial DNA binding to human neutrophil surface. Lab Invest 288(9):926–937CrossRef

14.

Pasare C, Medzhitov R (2005) Control of B-cell responses by toll-like receptors. Nature 438:364–368PubMedCrossRef

15.

Asselin-Paturel C, Trinchieri G (2005) Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 202:461–465PubMedCrossRef

16.

Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440PubMedCrossRef

17.

Deng GM, Verdrengh M, Liu ZQ, Tarkowski A (2000) The major role of macrophages and their product tumor necrosis factor alpha in the induction of arthritis triggered by bacterial DNA containing CpG motifs. Arthritis Rheum 43:2283–2289PubMedCrossRef

18.

Miyata M, Kobayashi H, Sasajima T, Sato Y, Kasukawa R (2000) Unmethylated oligo-DNA containing CpG motifs aggravates collagen-induced arthritis in mice. Arthritis Rheum 43:2578–2582PubMedCrossRef

19.

Veiko NN, Shubaeva NO, Ivanova SM, Speranskii AI, Lyapunova NA, Spitkovskii DM (2005) Blood serum DNA in patients with rheumatoid arthritis is considerably enriched with fragments of ribosomal repeats containing immunostimulatory CpG-motifs. Bull Exp Biol Med 142(3):313–316

20.

Lazarus R, Klimecki WT, Raby BA, Vercelli D, Palmer LJ, Kwiatkowski DJ et al (2003) Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case-control disease association studies (small star, filled). Genomics 81:85–91PubMedCrossRef

21.

Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C (2004) Crohn’s disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127:365–366PubMedCrossRef

22.

De Jager P, Richardson A, Vyse T, Rioux JS (2006) Genetic variation in Toll-like receptor 9 and susceptibility to systemic lupus erythematosus. Arthritis Rheum 54:1279–1282PubMedCrossRef

23.

Berghofer B, Frommer T, Konig IR, Ziegler A, Chakraborty T, Bein G et al (2005) Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevance. Clin Exp Allergy 35:1147–1154PubMedCrossRef

24.

Ito A, Ota M, Katsuyama Y, Inoko H, Ohno S, Mizuki N (2007) Lack of association of Toll-like receptor 9 gene polymorphism with Behçet’s disease in Japanese patients. Tissue Antigens 70(5):423–426PubMedCrossRef

25.

Carvalho A, Santos M, Maciel P, Rodrigues F (2008) T-1237C polymorphisms of TLR 9 gene is not associated with multiple sclerosis in the portuguese population. Mult Scler 14(4):550–552PubMedCrossRef

26.

Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C et al (2009) European Consortium on Rheumatoid Arthritis Families. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 11(1):R5

27.

Hamann L, Glaeser C, Hamprecht A, Gross M, Gomma A, Schumann RR (2006) Toll-like receptor (TLR)-9 promotor polymorphisms and atherosclerosis. Clin Chim Acta 364:303–307PubMedCrossRef

28.

Novak N, Yu CF, Bussmann C, Maintz L, Peng WM, Hart J et al (2007) Putative association of a TLR9 promoter polymorphism with atopic eczema. Allergy 62(7):766–772PubMedCrossRef

29.

Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607PubMedCrossRef

30.

Boule MW, Broughton C, Mackay F, Akira S, Marshak-Rothstein A, Rifkin IR (2004) Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199:1631–1640PubMedCrossRef

31.

Szodoray P, Alex P, Frank MB, Turner M, Turner S, Knowlton N et al (2006) A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis. Rheumatology 45:1466–1476PubMedCrossRef

32.

Rudnicka W, Burakowski T, Warnawin E, Jastrzebska M, Bik M, Kontny E et al (2009) Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients. Eur J Immunol 39(5):1211–1220PubMedCrossRef

33.

Barton GM, Miedzhitov R (2003) Toll-like receptor pathways. Science 300:1524–1525PubMedCrossRef

34.

Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, Wagner H (2000) Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J Exp Med 192:595–600PubMedCrossRef

35.

Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF (1998) A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95:588–593PubMedCrossRef

36.

Matsumoto M, Funami K, Oshiumi H, Seya T (2004) Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol 48:147–154PubMed

37.

Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413:732–738PubMedCrossRef

38.

Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S et al (2005) Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174:2942–2950PubMed

39.

Chuang T, Ulevitch R (2001) Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta 1518:157–161PubMed

40.

Bernasconi N, Onai N, Lanzavecchia A (2003) A role for Toll-like receptors in acquired immunity: up-regulation of TLR9 by BCR triggering in naive B cells and constitutive expression in memory B cells. Blood 101:4500–4504PubMedCrossRef

41.

Noguchi E, Nishimura F, Fukai H, Kim J, Ichikawa K, Shibasaki M, Arinami T (2004) An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34:177–183PubMedCrossRef

42.

Pirie FJ, Pegoraro R, Motala AA, Rauff S, Rom L, Govender T, Esterhuizen TM (2005) Toll-like receptor 3 gene polymorphisms in South African Blacks with type 1 diabetes. Tissue Antigens 66:125–130PubMedCrossRef

43.

Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S (2007) Toll like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. Br J Opthalmol 91:962–965CrossRef

44.

Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J, Vogelberg C, Weiland SK, von Mutius E, Kabesch M (2008) Toll-like receptor heterodimer variants protect from childhood asthma. J Allergy Clin Immunol 122(1):86–92PubMedCrossRef

45.

Stevens VL, Hsing AW, Talbot JT, Zheng SL, Sun J, Chen J, Thun MJ, Xu J, Calle EE, Rodriguez C (2008) Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer 123(11):2644–2650

Titel: The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients
verfasst von: Ebru Onalan Etem
Halit Elyas
Salih Ozgocmen
Arefe Yıldırım
Ahmet Godekmerdan
Publikationsdatum: 01.10.2011
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 10/2011
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1472-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2011

Coexistence of vasculitides with Familial Mediterranean Fever

Whole-body MRI in the childhood form of hypophosphatasia

Cholecystokinin octapeptide exerts its therapeutic effects on collagen-induced arthritis by suppressing both inflammatory and Th17 responses

Association analysis of TNFR2, VDR, A2M, GSTT1, GSTM1, and ACE genes with rheumatoid arthritis in South Asians and Caucasians of East Midlands in the United Kingdom

Vascular comorbidities in familial Mediterranean fever

Regional migratory osteoporosis: case report of a patient with neuropathic pain

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin